RVMD — Revolution Medicines Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapMomentum Trap

Annual balance sheet for Revolution Medicines, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	123	441	577	645	1,853
Net Total Accounts Receivable
Net Total Receivables	8.74	6.39	5.93	4.67	1.25
Prepaid Expenses
Total Current Assets	134	454	590	660	1,879
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7.15	36.3	71.2	73.7	100
Net Goodwill
Net Intangible Assets
Other Long Term Assets
Total Assets	221	567	738	812	2,062
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	43.1	47.2	60.4	62	144
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	68	92.7	135	127	236
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Total Equity	153	475	603	685	1,826
Total Liabilities & Shareholders' Equity	221	567	738	812	2,062
Total Common Shares Outstanding